Prilosec erosion
Executive Summary
Substitution of generic omeprazole is 12% of total scripts, 19% of new according to Jan. 5 data, Schwarz AG CEO Klaus Veitinger reported Jan. 8 at J.P. Morgan H&Q Conference in San Francisco. Schwarz subsidiary Kudco is distributing the generic of AstraZeneca's proton pump inhibitor Prilosec to mail order operations on limited basis due to manufacturing limitations (1"The Pink Sheet" Dec. 16, 2002, p. 30). Mail order aided sweeping substitution of generic fluoxetine (Lilly's Prozac), which had 80% mail service conversion rate in one week (2"The Pink Sheet" Aug. 27, 2001, p. 8). Express Scripts' 2001 Drug Trend Report predicted that, if introduced by December, generic omeprazole market share would reach 17% by end of 2003 (3"The Pink Sheet" June 17, 2002, p. 12)...
You may also be interested in...
Schwarz Omeprazole Launch Is Limited By Manufacturing Capacity
The limited manufacturing capacity of Schwarz' subsidiary Kremers Urban Development Co. means the company will supply generic omeprazole to all major pharmacy chains and drug wholesalers, but will distribute to mail order operations on a limited basis
Boston Scientific Pays More Than $1Bn For Lumenis’ Surgical Laser Business
Lumenis’ surgical business includes the MOSES laser system for minimally invasive urology surgery which will complement Boston Scientific’s LithoVue ureteroscope.
Finance Watch: Eleven Companies Reveal $1.45bn In $100m-Plus VC Deals
Private Company Edition: Clover’s $230m financing was the largest of recent mega-rounds. Century Therapeutics ($160m), Vividion ($135m) and eGenesis ($125m) also raised big rounds and investors Foresite Capital ($969m), Sofinnova Partners ($540m) and OMX Ventures ($150m) raised new VC funds.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: